Sampre Nutritions Intrinsic Value
Sampre Nutritions (SAMPRE) median intrinsic value is ₹17.65 from 8 valuation models (range ₹11–₹21), vs current price ₹7.06 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Sampre Nutritions stock price NSE.
SAMPRE Valuation Methods Summary — DCF, Graham Number & P/E
Sampre Nutritions intrinsic value across 8 models vs current price ₹7.06 — upside/downside and value range per method. Analyse SAMPRE institutional holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹21.18 | ₹16.94 - ₹25.42 | +200.0% | EPS: ₹2.56, Sector P/E: 12x |
| Book Value Method | asset | ₹17.65 | ₹15.88 - ₹19.41 | +150.0% | Book Value/Share: ₹43.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹14.12 | ₹12.71 - ₹15.53 | +100.0% | Revenue/Share: ₹30.48, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹11.43 | ₹10.29 - ₹12.57 | +61.9% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹17.65 | ₹14.12 - ₹21.18 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹16.38 | ₹14.74 - ₹18.02 | +132.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹21.09 | ₹18.98 - ₹23.20 | +198.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹21.18 | ₹19.06 - ₹23.30 | +200.0% | EPS: ₹2.56, BVPS: ₹43.33 |
SAMPRE Intrinsic Value vs Market Price — All Valuation Models
Sampre Nutritions fair value range ₹11–₹21 vs current market price ₹7.06 across 8 valuation models. Read Sampre Nutritions dividend payments for the complete payout history and dividend yield track record.
SAMPRE Intrinsic Value Analysis — Undervalued or Overvalued?
Sampre Nutritions median intrinsic value ₹17.65, current price ₹7.06 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of SAMPRE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sampre Nutritions (SAMPRE) is ₹17.65 (median value). With the current market price of ₹7.06, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹11.43 to ₹21.18, indicating ₹11.43 - ₹21.18.
Is SAMPRE undervalued or overvalued?
Based on our multi-method analysis, Sampre Nutritions (SAMPRE) appears to be trading below calculated value by approximately 150.0%.
SAMPRE Financial Health — Key Ratios vs Industry Benchmarks
Sampre Nutritions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.45 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SAMPRE Cash Flow Quality — Operating & Free Cash Flow
Sampre Nutritions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-38 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |